137 results
8-K
EX-10.1
AGRX
Agile Therapeutics Inc
23 Feb 24
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
4:30pm
of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which
8-K/A
EX-10.1
xry2na533z82y984xc
22 Aug 23
Departure of Directors or Certain Officers
8:30am
8-K/A
dpwmh77hdiv
22 Aug 23
Departure of Directors or Certain Officers
8:30am
8-K
ftihiielke4rri6zuyk
27 Jun 23
Departure of Directors or Certain Officers
4:46pm
S-8
EX-99.1
m9jvxn7j
9 Jun 23
Registration of securities for employees
5:19pm
8-K
EX-10.1
xqhb6z
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
424B4
427nqiu8cs79r
24 May 23
Prospectus supplement with pricing info
4:05pm